Viewing Study NCT02322593


Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2026-02-24 @ 2:30 PM
Study NCT ID: NCT02322593
Status: COMPLETED
Last Update Posted: 2021-12-20
First Post: 2014-12-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase III Study of TAS-118 Plus Oxaliplatin Versus S-1 Plus Cisplatin in Patients With Advanced Gastric Cancer
Sponsor: Taiho Pharmaceutical Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastric Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Gastric Cancer View
None Gastrointestinal Diseases View
None Gastrointestinal Neoplasms View
None First Line Treatment View
None Antineoplastic Agents View